Semax, a peptide derived from ACTH, has been studied for its potential effects on glucose metabolism, although the evidence does not conclusively establish it as a direct glucose-control agent. Instead, it appears to influence glucose metabolism indirectly through various mechanisms, including stress-axis modulation, brain energy-stress adaptation, inflammation, oxidative stress, and neurotrophic signaling [4].
What the AI assistants say
The AI assistants collectively suggest that Semax does not have a well-established direct effect on improving glucose metabolism. Instead, it may increase blood glucose levels in a small percentage of diabetic patients, which is considered a metabolic adverse effect [1]. While Semax is known to upregulate BDNF, which has glucose-modulating properties in preclinical models, there is no robust human evidence that Semax improves insulin sensitivity, glucose tolerance, or glycemic control [1]. The AI assistants also agree that Semax’s primary mechanism involves BDNF/TrkB signaling and mitochondrial function, with BDNF activating TrkB, which in turn supports mitochondrial glucose metabolism under oxidative stress [1]. Additionally, Semax binds to melanocortin 4 receptor (MC4R), which is implicated in energy homeostasis and glucose regulation [1]. However, the AI assistants differ in their views on the extent to which Semax influences glucose metabolism, with some suggesting potential indirect effects through modulation of neurotransmitter systems and neuroprotection, while others emphasize the lack of direct evidence for glucose-lowering effects in humans [2][3].
What the research actually shows
According to the research corpus, Semax demonstrates several properties that could influence glucose metabolism indirectly:
-
Neuroprotective Effects and Mitochondrial Stability: Semax is described as a neuroprotective agent that contributes to mitochondrial stability under stress induced by the deregulation of calcium ion flow [4].
-
Expression of BDNF and TrkB Receptor: Semax elevates the expression of brain-derived neurotrophic factor (BDNF) and its receptor TrkB [4].
-
Activation of Dopaminergic and Serotonergic Systems: Semax activates dopaminergic and serotonergic systems [4].
-
Antidepressant and Anxiolytic Effects: Semax can work as an antidepressant and an anxiolytic, attenuating chronic stress effects [4].
-
Potential Melanocortin Antagonism: Semax is a potential melanocortin antagonist, targeting receptors MC3R and MC4R [4].
-
Applications in Cognitive Disorders and Immune System: Semax is used to help with memory and cognitive disorders and boosts the immune system [4].
-
Interaction with HGF in Neurodegenerative Diseases: In the context of neurodegenerative diseases like Parkinson’s, Semax works with hepatocyte growth factor (HGF) [4].
The research corpus does not provide direct evidence that Semax lowers fasting glucose, improves insulin sensitivity, reduces HbA1c, or treats diabetes in humans [4]. Instead, it suggests that Semax’s effects on glucose metabolism are likely indirect, through its neuroprotective properties, influence on neurotransmitter systems, stress-reducing effects, and interactions with growth factors [4].
Where the AI consensus and the research diverge
The AI assistants and the research corpus agree that Semax does not have a direct, proven effect on glucose metabolism. However, the AI assistants place more emphasis on the potential for Semax to influence glucose metabolism through BDNF upregulation and melanocortin receptor activation, while the research corpus highlights a broader range of potential mechanisms, including the modulation of neurotransmitter systems and the reduction of chronic stress effects. Both sources acknowledge the lack of robust human evidence for Semax’s effects on glucose metabolism.
Bottom line: While Semax may indirectly influence glucose metabolism through various physiological effects, there is no direct evidence from the research corpus to support its use as a glucose-control agent in humans.
References
- Basic and Clinical Aspects of Growth Hormone
- Endocrinology_ Adult and Pediatric
- GHRH, GH, and IGF-1_ Basic and Clinical Advances
- GLP-1_ A New Drug for the Treatment of Type 2 Diabetes
- Gene and Cell Therapy_ Therapeutic Mechanisms and Strategies
- Glucose Shortens the Life Span of C elegans by — Seung-Jae Lee
- Goodman and Gilman's The Pharmacological Basis of Therapeutics
- Hypothalamic Integration of Energy Metabolism
- Islet Transplantation_ Clinical and Experimental
- Metabolic Syndrome_ Underlying Mechanisms and Drug Therapies
- Neuroanatomy of Metabolic Control
- Neuroprotective Effects of Tripeptides—Epigenetic Regulators — Khavinson, Vladimir (author)
- Peptide Protocols Volume One — William A Seeds MD
- Peptide drug discovery and development _ Translational — edited by Miguel Castanho and
- Selenium_ Its Molecular Biology and Role in Human Health
- The role of CNS fuel sensing in energy and glucose regulation
- The role of bile acids in the pathophysiology and treatment of type 2 diabetes
- Therapeutic fasting as a potential effective treatment for type 2 diabetes_ A 4-month case study
- Williams Textbook of Endocrinology
Continue your research
Part of our Semax: Metabolic & Body Composition guide.
- How does Semax influence metabolic processes in the body?
- What are the metabolic pathways influenced by Semax?
- What are the effects of Semax on energy metabolism and mitochondrial function?
Related topics:
- How does Semax exert its neuroprotective effects?
- What are the effects of Semax on the dopaminergic system?
- What is the optimal dosing regimen for Semax to achieve maximum therapeutic effects?